Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT (Q3957989): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: EU contribution (P835): 968,650.702 euro) |
(Changed an Item: Fixing rounding issue) |
||||||||||||||
Property / EU contribution | |||||||||||||||
968,650.70 Euro
| |||||||||||||||
Property / EU contribution: 968,650.70 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 968,650.70 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.00276521 Euro
| |||||||||||||||
Property / EU contribution: 968,650.70 Euro / qualifier | |||||||||||||||
point in time: 6 December 2021
|
Revision as of 09:48, 15 December 2021
Project Q3957989 in Hungary
Language | Label | Description | Also known as |
---|---|---|---|
English | Development of a new recombinant serum albumin-based radiopharmaceutical 99mTc and 68Ga-labelled radiopharmaceutical for lung SPECT/CT and PET/CT |
Project Q3957989 in Hungary |
Statements
350,299,146 forint
0 references
47.462349 percent
0 references
2 January 2018
0 references
31 December 2019
0 references
MEDI-RADIOPHARMA Egésszségügyi Szervező, Tanácsadó, Szolgáltató és Kereskedelmi Korlátolt Felelősségű Társaság
0 references
Érd, Pest
0 references
Identifiers
VEKOP-2.1.1-15-2016-00082
0 references